Originally published In Press as doi:10.1074/jbc.M111382200 on February 19, 2002
J. Biol. Chem., Vol. 277, Issue 17, 14483-14492, April 26, 2002
The Chain Length Dependence of Helix Formation of the Second
Transmembrane Domain of a G Protein-coupled Receptor of
Saccharomyces cerevisiae*
Fa-Xiang
Ding
,
David
Schreiber
,
Nathan C.
VerBerkmoes§¶,
Jeffrey M.
Becker§
, and
Fred
Naider
**
From the
Department of Chemistry, The College of
Staten Island of the City University of New York, Staten Island,
New York 10314, the § Graduate School of Genome Science and
Technology, University of Tennessee-Oak Ridge National Laboratory, Oak
Ridge, Tennessee 37830-8026, the ¶ Organic and Biological Mass
Spectrometry Group, Oak Ridge National Laboratory, Oak Ridge, Tennessee
38731-6365, and the
Department of Microbiology and Department of
Biochemistry, Cellular and Molecular Biology, University of Tennessee,
Knoxville, Tennessee 37996
Received for publication, November 29, 2001, and in revised form, February 3, 2002
 |
ABSTRACT |
The chain length dependence of
helix formation of transmembrane peptides in lipids was
investigated using fragments corresponding to the second transmembrane
domain of the
-factor receptor from Saccharomyces
cerevisiae. Seven peptides with chain lengths of 10 (M2-10;
FKYLLSNYSS), 14 (M2-14), 18 (M2-18), 22 (M2-22), 26 (M2-26), 30 (M2-30)
and 35 (M2-35; RSRKTPIFIINQVSLFLIILHSALYFKYLLSNYSS) residues,
respectively, were synthesized. CD spectra revealed that M2-10 was
disordered, and all of the other peptides assumed partially
-helical secondary structures in 99% trifluoroethanol (TFE)/H2O. In 50% TFE/H2O, M2-30 assumed a
-like structure. The other six peptides exhibited the same CD
patterns as those found in 99% TFE/H2O. In
1,2-dimyristoyl-sn-glycero-3-phosphocholine/1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) (4:1 ratio) vesicles, M2-22, M2-26, and M2-35 formed
-helical structures, whereas the other peptides formed
-like structures. Fourier transform infrared spectroscopy in
1,2-dimyristoyl-sn-glycero-3-phosphocholine/1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) (4:1) multilayers showed that M2-10, M2-14, M2-18, and M2-30 assumed
-structures in this environment. Another homologous 30-residue peptide (M2-30B), missing residues SNYSS from the N terminus
and extending to RSRKT on the C terminus, was helical in lipid
bilayers, suggesting that residues at the termini of transmembrane
domains influence their biophysical properties. Attenuated total
reflection Fourier transform infrared spectroscopy revealed that M2-22,
M2-26, M2-30B, and M2-35 were
-helical and oriented at angles of
12°, 13°, 36°, and 34°, respectively, with respect to the
multilayer normal. This study showed that chain length must be taken
into consideration when using peptides representing single
transmembrane domains as surrogates for regions of an intact receptor.
Furthermore, this work indicates that the tilt angle and conformation
of transmembrane portions of G protein-coupled receptors may be
estimated by detailed spectroscopic measurements of single
transmembrane peptides.
 |
INTRODUCTION |
The folding and structure of integral membrane proteins is driven
by entropic factors that cause the apolar side chains of many amino
acid residues to seek the interior of lipid bilayers and enthalpic
factors that require that the hydrogen bond potential of the peptide
group be satisfied in the low dielectric membrane interior (1).
Thermodynamic analyses indicate that the
-helix is the most favored
conformation of membrane-spanning regions of proteins. Indeed, it is
believed that preassembled
-helices form in the aqueous cytoplasm of
the cell and then insert into the bilayer (2). The thickness of the
hydrocarbon milieu of the bilayer depends on the fatty acid composition
and is often assumed to be about 30 Å. On this basis, the minimum
number of residues that can form an
-helix and span the bilayer is
predicted to be 20. However, this prediction assumes that the peptide
inserts into the membrane parallel to the bilayer normal.
Recent x-ray studies on integral membrane proteins and in particular on
rhodopsin show that not all of the transmembrane helices of this
protein orient normal to the bilayer (3, 4). Thus, in some cases, more
than 20 residues will be required to span the bilayer. Similar
conclusions are reached upon inspection of other crystal structures
(5-7). Unfortunately, the number of crystal structures for membrane
proteins remains very small in comparison with the proportion of these
molecules in cells (8, 9). Accordingly, many investigators are using
peptide fragments as model compounds to examine the biophysical and
structural tendencies of transmembrane regions of these proteins (10,
11).
An unresolved question in these studies is the appropriate length of
the model peptide and the influence of length on the ability of the
peptide to assume a stable helix in bilayers. This question is
important because amino acid residues in transmembrane regions of a
protein are often those, such as Val, Ile, and Phe, that assume
-sheet structures in globular proteins (12). Although Deber and
co-workers (13, 14) have demonstrated that the secondary structural
preferences of amino acid residues are context-dependent and that these residues have high helix-forming tendencies in membrane
mimetic solvents, this correlation was determined using peptides of a
constant length. Studies with short peptides indicate that in solution
-sheet formation is maximum for peptides containing 8-12
residues (15).
We have been conducting a detailed biophysical analysis on synthetic
peptides corresponding to putative domains of the
-factor receptor
of the yeast Saccharomyces cerevisiae. This G
protein-coupled receptor recognizes the tridecapeptide pheromone
(WHWLQLKPGQPMY-
-factor) and triggers a cascade of intracellular
events ultimately resulting in sexual conjugation and diploid formation
(16, 17). Studies on fragments of the receptor using CD (18, 19), IR
(20), and NMR spectroscopies (21, 22) have revealed the conformational tendencies of the seven transmembrane domains and, in the case of IR
analysis, gave information on the orientation of the peptides in lipid bilayers.
In the present communication, we focus on the second transmembrane
domain of Ste2p. Peptides of various chain lengths corresponding to the
sequence of this domain were synthesized (see Table I for the
nomenclature used in this paper and the sequences of the peptide
fragments) and examined using both CD spectroscopy and IR spectroscopy
to determine their secondary structural preferences and orientation in
lipid bilayers. The results provide insights into the influence of
peptide chain length on both the propensity of these peptides to form
helices in lipid bilayers and their helical orientation in multilayers.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Wang resin,
Fmoc1-protected amino acids,
O-benzotriazolyl-N,N,N',N'-tetramethyluronium
hexafluorophosphate, and 1-hydroxybenzotriazole were
purchased from Advanced ChemTech (Louisville, KY).
Diisopropylethylamine, dicyclohexylcarbodiimide, trifluoroacetic acid,
thioanisole, 1,2-ethanedithiol, and
4-N,N'-dimethylaminopyridine were purchased from
Aldrich. Solvents used for syntheses and purifications were purchased
from VWR Scientific Products (Piscataway, NJ) and Fisher.
Dimyristoylphosphocholine and dimyristoylphosphoglycerol sodium
salt were purchased from Avanti Polar Lipids (Alabaster, AL).
Peptide Synthesis--
Eight peptide fragments with different
chain lengths corresponding to the sequence of the second Ste2p
transmembrane domain were synthesized on a Wang resin using
-Fmoc
protection strategies. For the synthesis of all peptides except for
M2-30B (Table I), the first Fmoc-Ser(tBu)-OH (20-fold excess) was
loaded manually on a Wang resin (0.4 mmol of OH/g) using the
dicyclohexylcarbodiimide/4-N,N'-dimethylaminopyridine strategy in dichloromethane. Small amounts of unreacted OH groups on
the Wang resin were capped using a 100-fold excess of acetic anhydride
in the presence of 4-N,N'-dimethylaminopyridine.
After the peptide chain was manually elongated to three amino acid
residues (i.e. Fmoc-Tyr(tBu)-Ser(tBu)-Ser(tBu)-Wang resin),
the resin was loaded on a solid phase peptide synthesizer (model 433A;
Applied Biosystems). The coupling strategy utilized FastMoc chemistry with the use of extended coupling times. Double coupling was carried out for each residue using
O-benzotriazolyl-N,N,N',N'-tetramethyluronium hexafluorophosphate/1-hydroxybenzotriazole activation, and capping was
accomplished with acetic anhydride in the presence of
diisopropylethylamine. Approximately 15% of the resin was separated
from the reaction vessel when the peptide chain length reached 10, 14, 18, 22, 26, and 30 residues, respectively. Ultimately, the peptide was
elongated to 35 residues. In this strategy, seven portions of resin
with peptide chain lengths of 10, 14, 18, 22, 26, 30, and 35 were
obtained during one batch synthesis. The synthesis of M2-30B was
carried out using a Wang resin (0.4 mmol of OH/g) where the first
Fmoc-Leu-OH was loaded manually as described above. The resulting
Fmoc-Leu-Wang resin was then transferred to the synthesizer, and chain
assembly was completed.
Each portion of resin was treated with a cleavage solution containing
0.38 g of phenol, 0.25 ml of thioanisole, 0.12 ml of 1,2-ethanedithiol, 0.25 ml of water, and 5 ml of trifluoroacetic acid. The cleavage reaction was carried out at room temperature for 1.5 h. The reaction mixture was filtered, and the filtrate was
concentrated to a small volume on a rotary evaporator at room temperature. The crude peptides were precipitated by the addition of
anhydrous ether and collected by filtration. The crude peptides were
lyophilized from TFE/H2O (1:4) before purification.
Peptide Purification--
Peptides were purified on a
semipreparative µBondapak C18 HPLC column (19 × 300 mm) at room
temperature with elution solvents of water (0.1% trifluoroacetic acid)
plus acetonitrile (0.1% trifluoroacetic acid) at gradients from 10 to
80% acetonitrile over 90-120 min. All peptides were purified to over
98% homogeneity as judged by analytical reverse phase HPLC on a
µBondapak C18 column (3.9 × 300 mm) at room temperature with
linear gradients of water (0.025% trifluoroacetic acid) plus
acetonitrile (0.025% trifluoroacetic acid) or water (0.025%
trifluoroacetic acid) plus methanol (0.025% trifluoroacetic acid).
Detection was at 220 nm.
Mass Spectrometry Characterization--
The final products were
assessed by electrospray mass spectrometry to verify correct intact
molecular weight and sequence. Peptides were dissolved in
acetonitrile/H2O/acetic acid (50:50:1) at ~5 pmol/µl.
The solution was directly infused at a flow rate of 5.0 µl/min into
an electrospray ion trap (LCQ-DECA Thermo Finnigan) operating in the
positive ionization mode. All peptides were found to be within 0.5 daltons of the expected mass. The correct sequence order was confirmed
by collision-induced dissociation (MS/MS) on the M2-35 peptide. Since
all peptides except for M2-30B were synthesized on the same template,
portions of the sequence of the M2-35 peptide are replicated in each of
the shorter peptides. The +3 and the +4 charge state of the M2-35
peptide were individually isolated and fragmented. The resultant
product ions were compared with the theoretical ions from the M2-35
peptide. Fragment ions corresponding to 26 of the 35 amino acids were
identified. Furthermore, all ions above the background could be
attributed to the M2-35 sequence. No diagnostic product ions were
observed from the first 8 amino acids from the N terminus or the last
two from the C terminus. The last two amino acids on the C terminus are
both serine residues, so the order is equivalent, and the presence of
two serines was confirmed by an agreement between calculated and
measured values for the predicted fragment ion from the third residue
from the C terminus. The sequence of the 8 amino acids of the N
terminus was confirmed by 1H NMR spectroscopy. The longest
peptide with 35 residues had previously been confirmed by amino acid
analysis (19). The peptide synthesized in this study was identical with
the authentic sample as judged by co-injection on analytical HPLC.
Thus, the sequences of all peptides examined in this investigation have
been proven.
Preparation of Lipid-Peptide Vesicles for CD, FTIR, and
ATR-FTIR--
Peptides corresponding to the second Ste2p TMD
(0.17-0.57 mg in 0.10 ml of TFE/H2O (10:1)) were added to
4 mg of DMPC/DMPG (4:1) in 1 ml of CHCl3/CH3OH
(4:1). The resulting solution was dried under N2 flow.
Residual traces of organic solvent were removed by placing the dried
film under vacuum overnight, and the lipid was then resuspended in 1 ml
of 0.1 mM phosphate buffer, pH 6.3. The suspension was
sonicated at ~50 °C for 60 min in a W-385 sonicator (Misonix,
Inc., Farmingdale, NY) equipped with a cup horn (40% output power).
The vesicle preparation was exhaustively dialyzed three times into 600 ml of 0.1 mM phosphate buffer, pH 6.3, using Spectrapor 6 dialysis tubing with a 1000 molecular weight cut-off (VWR Scientific
Products). The resulting vesicles were then passed through a 0.45-µm
polycarbonate centrifugal filter. The calculated molar ratio of
peptides to lipid was about 1:50. The final peptide concentrations
ranged from 0.08 to 0.13 mM.
Circular Dichroism Measurements--
The CD spectra of the
peptides were recorded on an AVIV model 62 DS CD instrument (AVIV
Associates, Lakewood, NJ), which was interfaced with a computer used
for all mathematical calculations. Two cuvettes with light path lengths
of 0.02 and 0.1 cm were used for vesicle suspensions and
TFE/H2O solutions, respectively. All spectra were the
average of five scans between 300 and 190 nm at an interval of 1 nm
with a 1-s integration time at each wavelength. The bandwidth for each
measurement was 1 nm. Peptide concentrations in solution and vesicle
suspension were determined from UV absorbance using an extinction
coefficient of 1340 cm
1 M
1 for
a single tyrosine residue at 280 nm (23). Prior to calculation of the
final ellipticity, all spectra were corrected by subtracting the
reference spectra of TFE/H2O at the ratio of 99:1 or 50:50 or of a DMPC/DMPG (4:1) vesicle suspension in 0.1 mM
phosphate buffer (pH 6.3) without peptides. CD intensities are
expressed as mean residue ellipticities (degrees · cm2/dmol).
Estimation of
-Helical Percentage--
Estimation of
-helical percentages was made using a method initially suggested by
Greenfield and Fasman (24) and later modified by Wu et al.
(25) and Chen et al. (26). These methods use ellipticities
at either 208 or 222 nm and calculate fractional helicities as
follows,
|
(Eq. 1)
|
where [
] represents the experimentally observed mean
residue ellipticity; values for [
]0 and
[
]100 corresponding to 0 and 100% helical content at
222 nm were estimated to be 2000 and 30,000 degrees·cm2/dmol, respectively (25, 26).
FTIR and ATR-FTIR Spectroscopy--
FTIR spectra were recorded
at ambient temperature (~20 °C) on a Nicolet Magna 550 Fourier
transform infrared spectrometer (Nicolet Analytical Instruments,
Madison, WI) purged with N2 and equipped with a DTGS
detector and an ATR accessory (Pike Technologies, Inc., Madison, WI).
The infrared beam was polarized using a 1-inch diameter wire grid ZnSe
polarizer. For each sample, 1000 interferograms were averaged at a
spectral resolution of 4 cm
1 and processed using
one-point zero filling and Happ-Genzel apodization. For orientation
studies, lipid films on the top surface of germanium ATR crystals
(55 × 10 × 4 mm with 45° beveled edges) were obtained by
slowly evaporating the vesicle suspension (250 µl) in the presence or
absence of peptides. The ATR crystals were previously cleaned with
chloroform, TFE, and methanol, followed by 30-min plasma cleaning in a
PDC-32G cleaner (Harrick, Ossining, NY). For transmission spectra, 100 µl of sample was dried on a CaF2 window (25-mm diameter). Following deposition, the ATR crystals or CaF2 windows were
transferred to a desiccator, where the films were rehydrated by vapor
diffusion in an atmosphere maintained at 98% relative humidity using a
saturated solution of K2SO4 in water (27).
Rehydration was allowed to proceed for a minimum of 18 h at room
temperature. The spectrum for the respective phospholipid multilayers
without peptide was subtracted to yield the difference spectrum of each
peptide in the multilayer.
Peptide Amide H/D Exchange Experiment--
100 µl
of the preformed lipid vesicle with or without peptide was dried on the
surface of the CaF2 window (25-mm diameter). The windows
containing lipid films were rehydrated using the method described
above. After recording FTIR spectra from the hydrated film, it was
transferred to a dry box (i.e. an environment maintained at
less than 10% relative humidity using P2O5),
where it was dehydrated by storage at room temperature overnight. After
recording FTIR spectra from the dry film in order to confirm
dehydration, 8 µl of D2O was added directly to its
surface. The sample was tilted until the water had wet the entire
surface of the film and then incubated in the dry environment for 30 min in order to allow most of the excess D2O to evaporate.
Whereas some of bulk D2O was still visible on the surface
of the film, it was transferred to a sealed chamber maintained at a
relative humidity of 98% (in D2O) by a saturated solution
of K2SO4 in D2O. The amide exchange was allowed to proceed for 18 h. After all of the bulk
D2O had evaporated from the surface of the film, FTIR
spectra of the samples were recorded in a N2 environment.
Analysis of Orientation from ATR-FTIR Dichroism--
Order
parameters for the helical peptides were determined using established
methods (28-30). The measured dichroic ratio,
RATR, defined as the ratio between the
absorption of light polarized parallel and perpendicular to the surface
of the internal reflection element, was used to calculate an order
parameter (S) using Equation 2,
|
(Eq. 2)
|
in which Ex, Ey, and
Ez are the integrated absorption coefficients (31).
If the film refractive index is independent of the wavelength, Equation 2 can be written in a simplified form (Equation 3) by setting
Ex = 1.398, Ey = 1.516, and
Ez = 1.625 (32),
|
(Eq. 3)
|
in which
represents the angle between the principal
transition dipole moment and the molecular director;
= 39°
for the amide I mode (28). The order parameter S is related
to the tilt angle
from the normal of the internal reflection
element by Equation 4.
|
(Eq. 4)
|
Order parameters for the lipids are obtained from the symmetric
and asymmetric stretching modes of the lipid methylene groups by
setting
= 90°.
 |
RESULTS |
Peptide Design and Synthesis--
A peptide representing
the second transmembrane domain of Ste2p was designed to have the
sequence RSRKTPIFIINQVSLFLIILHSALYFKYLLSNYSS that extends from
Arg74 to Ser108 of the receptor. This peptide
includes the entire transmembrane hydrophobic region plus 6 extracellular and 5 cytoplasmic residues (19). The complete peptide
with the wild-type sequence was synthesized previously and found to
form a highly
-helical secondary structure in aqueous TFE, SDS
micelles, DMPC vesicles, and multilayers (19, 20). Therefore, the above
region of Ste2p was chosen to study the effect of chain length on the
secondary structures assumed by membrane peptides. We synthesized seven
peptide fragments with 10, 14, 18, 22, 26, 30, and 35 residues,
respectively, starting from the carboxyl-terminal serine
(Ser108). These peptide fragments were named M2-10, M2-14,
M2-18, M2-22, M2-26, M2-30, and M2-35, respectively, in which M2
represents the second transmembrane domain and the number following M2-
represents the chain length of these peptide fragments (19). The
peptides were prepared using solid-phase peptide chemistry. To examine the influence of loop residues on the biophysical properties of the
second transmembrane domain, one peptide lacking SNYSS (M2-30B) was
also synthesized.
Membrane peptides usually contain regions that are predominantly
hydrophobic, and peptide chains that are assembled on a resin matrix
can aggregate either with other peptide chains or with the polymer
support. Therefore, low loading substitution of the resin (less than
0.4 mmol/g) was selected for this synthesis. Fmoc-Ser(tBu)-Ser(tBu)-Wang resin was not stable during the standard deprotection in the presence of 20%
piperdine/N,N-dimethylformamide, possibly
due to diketopiperazine formation upon Fmoc removal. It was determined
that using 10%
piperidine/N,N-dimethylformamide (5 ml for
0.1-mmol scale of resin) for 10 min to deprotect
Fmoc-Ser(tBu)-Ser(tBu)-Wang resin followed by immediate reaction with
the next amino acid residue minimized the loss of peptide chains.
Completion of the deprotection and subsequent coupling reaction were
carefully monitored by UV absorbance of the dibenzofulvene-piperidine adduct.
CD Analysis--
The shape and intensity of a CD spectrum between
180 and 240 nm are sensitive to protein secondary structure. As the
Ste2p receptor protein is localized to the plasma membrane in
Saccharomyces cerevisiae, all of the fragments were analyzed
using CD spectroscopy in membrane mimetic media including aqueous TFE
and DMPC/DMPG (4:1) vesicles. Qualitative analysis of the
-helicity
of a peptide by CD spectroscopy is based on the discernment of
characteristic peak shapes. In particular, double minima at 222 and 208 nm and a ratio of the magnitudes of the molar ellipticities at 195 and 222 nm greater than or equal to 2.5:1 are indicative of
-helical structures (33), whereas a single minimum at 217 nm and a maximum at
197 nm are indicative of
-structures (34-36). Quantitative analysis
of these CD spectra was carried out using the ellipticity at 222 nm to
approximate percent
-helicities as described under "Experimental
Procedures." Estimated
-helicities are listed in Table
I. It should be noted that calculations
based on the mean residue ellipticity at 222 nm are not significantly
affected by the presence of His residue, since the contribution of the
imidazole chromophore to the CD spectrum at 222 nm is negligible (37, 38).
View this table:
[in this window]
[in a new window]
|
Table I
Helicities (%) for fragments of the second Ste2p TMD in different
membrane mimetic environments
The helicities were calculated using [ ] values at 222 nm.
|
|
CD Spectroscopy of Peptides in Aqueous TFE--
CD spectra of all
the peptide fragments in aqueous TFE at the ratio of 99:1 and 50:50 are
presented in Fig. 1. As judged by the
double minima at 222 and 208 nm and the ratio of the magnitudes of the
molar ellipticities at 195 and 222 nm, all of the peptides except for
M2-10 show predominantly
-helical secondary structure in 99%
TFE/H2O. The M2-10 peptide is predominantly disordered in
both solvent mixtures. None of the
-helical peptides was less than
44% helical in this medium (Table I). With the exception of M2-30,
increasing the concentration of water from 1 to 50% did not
significantly affect the CD spectra of the M2 peptides (Fig. 1). The CD
spectrum of M2-30 undergoes a shift from that of an
-helix to that
of a
-sheet-like structure based on a minimum near 215 nm and the
absence of the double minima at 208 and 222 nm. The results showed that
in aqueous TFE the formation of
-helix begins at M2-14 and increases
with chain length with the obvious exception of M2-30. The conformation
of the latter peptide is dependent on the water concentration.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
CD spectra of synthetic peptides of the
second Ste2p TMD in TFE-H2O at ratios of 99:1
(solid line) and 50:50 (dashed
line). The final peptide concentrations ranged
from 20 to 30 µM.
|
|
CD Spectroscopy of Peptides in DMPC/DMPG (4:1) Vesicles--
CD
analysis of the eight peptides in DMPC/DMPG (4:1) vesicles indicates
that M2-10, M2-14, M2-18, and M2-30 exhibit a broad minimum near 215 nm
and a maximum near 193 nm (Fig. 2). In
contrast, M2-22, M2-26, M2-30B, and M2-35 have CD patterns
characterized by double minima at 208 and 222 nm, a maximum near 195 nm, and ratios of the molar ellipticity at 195 nm to that at 222 nm of 3.3, 3.3, 2.9, and 2.5, respectively. The estimated
-helicities for
M2-22, M2-26, M2-30B, and M2-35 are 58, 61, 58, and 92%, respectively (Table I). Control studies showed that except for M2-10, all of the
other peptides were nearly insoluble in phosphate buffer. The
10-residue peptide had very low solubility, and the small amount of
sample that dissolved gave a random coil CD pattern (data not shown).
The results indicate that there is a critical chain length between 18 and 22 residues for
-helix formation for peptides corresponding to
the second transmembrane domain of Ste2p in the lipid-like environment.
Notably, M2-30 did not form a stable
-helical secondary structure in
DMPC/DMPG (4:1) vesicles and exhibited a CD pattern indicative of a
-sheet structure (Fig. 2).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
CD spectra of synthetic peptides of the
second Ste2p TMD in DMPC/DMPG (4:1) vesicles suspended in 0.1 mM phosphate buffer at pH 6.3. The peptide lipid molar
ratio was about 1:50, and the final peptide concentrations ranged from
0.08 to 0.13 mM.
|
|
Secondary Structures of Peptides in DMPC/DMPG Multilayers--
The
correlation between the frequency of the amide I (primarily a carbonyl
stretching mode) vibrational mode and the secondary structure of a
polypeptide has been well established in the literature (39).
Frequencies in the region of 1650-1660 cm
1 correspond to
-helical segments, while modes vibrating in the region of 1630-1640
cm
1 and 1670-1685 cm
1 correspond to
-sheet elements. FTIR spectra of all the peptides in DMPC/DMPG (4:1)
multilayers are presented in Fig. 3.
M2-10, M2-14, M2-18, and M2-30 all have major absorbances between 1620 and 1630 cm
1 (Fig. 3 and Table
II). In the case of M2-14 and M2-18, this
absorbance dominates the amide I region, whereas for M2-10 and M2-30
additional absorbances were noted at 1664 and 1657 cm
1,
respectively. A shoulder at 1657 cm
1 for the amide I of
M2-30 probably reflects a small amount of
-helical structure. The
shoulder at 1664 cm
1 for the amide I of M2-10 may be due
to disordered chains. The FTIR spectra suggest that all of these
peptides assume significant amounts of
-sheet structures in
DMPC/DMPG multilayers. In contrast, M2-22, M2-26, M2-30B, and M2-35 all
exhibit major absorbances at 1657 or 1658 cm
1, indicating predominantly
-helical secondary
structures for these peptides in DMPC/DMPG (4:1) multilayers. These
results are fully in concordance with the CD analyses in the presence
of vesicles (Fig. 2).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 3.
Amide I and amide II regions of the FTIR
spectra of seven fragments of the second transmembrane domain of Ste2p
in phospholipid multilayers on CaF2 windows. Spectra
were measured in DMPC/DMPG (4:1) multilayers hydrated in 98%
H2O relative humidity (solid line) or
in 98% D2O relative humidity (dashed
line).
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Amide I and II frequencies and H/D exchange data for fragments of the
second Ste2p TMD in DMPC/DMPG (4:1) multilayers
|
|
Amide Proton H/D Exchange in Peptide/DMPC/DMPG
Multilayers--
Amide proton H/D exchange occurs slowly in the
hydrophobic environment of the multilayer, since this would require
disruption of the backbone hydrogen bonding pattern and exposure of the
highly polar peptide bonds in an extremely hydrophobic environment
(40-42). Thus, measurement of the extent of such exchange by observing the reduction in the amide II mode (a coupling of N-H rocking and C-N
stretching modes) provides a reliable indication of the penetration of
the peptide into the membrane (43). Accordingly, we used amide H/D
exchange to estimate the percentage of the residues in peptide
fragments of the second domain of the Ste2p receptor, which were
protected by DMPC/DMPG (4:1) multilayers. The results from equivalent
experiments on M2-10, M2-14, M2-18, M2-22, M2-26, M2-30, M2-30B, and
M2-35 in DMPC/DMPG (4:1) multilamellar films are presented in Fig. 3
and Table II. For all of the peptides, between 58 and 95% of the amide
protons are protected from H/D exchange during an 18-h exposure of the
peptides in phospholipid multilayers to 98% D2O relative
humidity. The protected residues must be participating in some kind of
structural interaction that prevents their backbone protons from
exchanging with bulk solvent. One explanation is that significant
proportions of the peptides were buried in the hydrophobic multilayers.
ATR-FTIR Spectroscopy of M2-22, M2-26, and M2-30B in DMPC/DMPG
(4:1) Multilayers--
M2-35 is predicted by hydropathy analysis to
have 24 transmembrane, 5 cytoplasmic, and 6 extracellular residues.
Previously, its
-helix was found to orient at an angle of 34°
relative to the multilayer normal in DMPC/DMPG multilayers (20). To
investigate the orientations of the predominantly
-helical M2-22,
M2-26, and M2-30B with respect to the multilayer normal (28, 32, 39,
44, 45), we recorded their ATR-FTIR spectra in DMPC/DMPG multilayers.
The orientations of the lipid chains of dry films in the presence of
peptides were determined from the dichroism of the CH2 stretching vibrations at 2850 cm
1 (symmetric) and 2918 cm
1 (asymmetric) in the ATR-FTIR absorbance spectra. The
dichroic ratios averaged from four independent experiments were between 1.01 and 1.11 (Table III). Assuming that
the transition dipole moment of the symmetric CH2
stretching vibration is perpendicular to the molecular axis, the
resulting calculated order parameters, S, of the acyl chains were
between 0.73 and 0.78, and the average tilt angles,
, of the
lipid's CH2 axis were between 25 and 23°, in agreement
with the results for well ordered fatty acid chains in the gel phase
(46). These results indicate that the peptides examined do not affect
either the structure or the orientation of the multilamellar phase.
View this table:
[in this window]
[in a new window]
|
Table III
ATR-FTIR dichroic ratios, order parameters, and calculated tilt angles
for M2-22, M2-26, and M2-30B in DMPC/DMPG (4:1) multilayers
|
|
ATR-FTIR spectra of the amide I regions were measured for M2-22, M2-26,
and M2-30B in DMPC/DMPG (4:1) multilayers, and their Fourier
self-deconvoluted spectra were calculated (see Fig.
4) (47). The dichroic ratios,
RATR, calculated from the Fourier
self-deconvoluted
-helical amide I vibrational regions integrated
from 1650 to 1665 cm
1, along with the respective order
parameter S and tilt angles
, are summarized in Table
III. The dichroic ratio values, RATR, for M2-22,
M2-26, and M2-30B were calculated to be 4.13, 4.07, and 2.85, respectively, resulting in corresponding order parameters of 0.94, 0.92, and 0.49. These results indicate that the axis of the
-helices
of M2-22, M2-26, and M2-30B orient at angles of 12, 13, and 36°,
respectively, with respect to the multilayer normal. For reference
purposes, the tilt angle of M2-35, reported to be 34° (20), was
confirmed in this work (data not shown).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 4.
Amide I region of ATR-FTIR spectra of M2-22,
M2-26, and M2-30B of the second Ste2p TMD in DMPC/DMPG(4:1) multilayers
on germanium crystals. Parallel (solid line)
and perpendicular (dashed line) polarizations are
shown in the spectrum. A, ATR-FTIR absorbance spectra;
B, Fourier self-deconvoluted spectra of A using a
bandwidth at half-height of 13 cm 1 and an enhancement of
2.0 (47).
|
|
 |
DISCUSSION |
The major objective of this investigation was to
determine the chain length dependence of helix formation and tilt
angles for transmembrane domains in membrane multilayers. As a
paradigm, we chose the second transmembrane domain of the
-factor
receptor of Saccharomyces cerevisiae, which had previously
been found to be highly helical (19, 20). CD results showed that in
99% TFE/H2O and in 50% TFE/H2O solutions, the
critical chain length for helix formation by these peptides was between
10 and 14 residues. In contrast, in DMPC/DMPG (4:1) vesicles or
multilayers, ~8 more residues were necessary to form a helical
structure. ATR-FTIR results indicated that helices of M2-22 and M2-26
oriented nearly parallel to the multilayer normal, whereas M2-35 tilted
at an angle of 34°. Most notable is the observation that M2-30
appeared to assume a
-like structure both in 50%
TFE/H2O and in the presence of DMPC/DMPG (4:1) vesicles or multilayers.
The critical chain length for helix formation of oligopeptides in
solution has been extensively investigated by Goodman and co-workers
(48). Homo-oligopeptides often begin forming helical structures at 7 residues in organic solvents. In aqueous medium, the chain length
required for helix formation is appreciably longer. Baldwin and
co-workers (49) demonstrated that at low temperature, a 17-residue
peptide composed predominantly of alanine residues could assume an
-helical structure. In other studies, slightly shorter peptides
could form helices in aqueous environments by forming a four-helix
bundle (50). The formation of the
-helix for polypeptides has also
been reported to have a critical chain length in the solid state
(51-54). The exact chain length required for helix formation depended
on sequence and sample preparation. Oligomers below the critical chain
length or in a nonequilibrium state assume
-aggregates. Longer
peptides generally form more stable
-helices.
Detailed information on the three-dimensional structure of the Ste2p is
not yet available due to its refraction to crystallization. Indirect
information on the structure of this GPCR has been obtained by
investigation of seven putative TMDs obtained by chemical synthesis. CD
analyses on these peptides have been conducted in both phospholipid bilayers and aqueous TFE solutions (19). TFE is a well known inducer of
-helices for peptides (55). Previously, we found that titration of
TFE-peptide solutions with water reduced the helicities of the
synthetic TMDs of the
-factor receptor and that the secondary
structures of TMDs in DMPC bilayers were often similar to those
observed in certain TFE/H2O mixtures. For example, a
31-residue peptide corresponding to the sixth transmembrane domain of
Ste2p was 57% helical in TFE but had CD patterns indicative of the
presence of
-structures in both 25% TFE/H2O and in DMPC bilayers (19). These results suggest that useful information about the
conformational preferences of transmembrane regions in membrane lipids
can be discerned from studies in aqueous trifluoroethanol. Indeed, a
detailed NMR study of the seven TMDs of Ste2p in TFE/H2O (4:1) has provided new insights into the secondary structures assumed
by specific amino acids in these membrane
peptides.2
In the present study, the critical chain lengths for structure
formation of peptides representing the second transmembrane domain of
Ste2p were between 10 and 14 residues in aqueous TFE and between 18 and
22 residues in DMPC/DMPG (4:1) as judged by both CD and IR analyses.
Three groups have reported hydropathy analyses on Ste2p (18, 56, 57).
These analyses differ very slightly in the residues placed at the
membrane interface and the number of residues actually in the bilayer.
Two of the analyses predicted 24 transmembrane residues in the second
TMD (18, 56), whereas the third predicted that only 21 residues of this
domain would be in the bilayer. Given these predictions and assuming that the SNYSS sequence could enter the hydrophobic region of the
bilayer, only M2-22, M2-26, M2-30, and M2-35 have sufficient residues
to fully span the lipid. The shorter peptides M2-10, M2-14, and M2-18
would not be able to form helical structures that completely cross the
lipid bilayer. Thus, on first analysis the ability of the M2 peptides
to form helical structures is correlated partially to the need to form
a helical structure that crosses the bilayer.
A previous study on synthetic peptides composed of Leu and Ala and
flanked by Trp residues (WALP peptides) concluded that hydrophobic
mismatch was a determinative factor in the integration of peptides into
bilayers (58). Peptides forming
-helices that were significantly
shorter or significantly longer than the hydrocarbon span of the lipid
were excluded from the membrane (58). In the present study, it is
important to note that only peptide associated with the lipid was
examined spectroscopically. The dialysis step used in the sample
preparation removed free peptide, and it was determined that, with the
exception of M2-10, the other peptides did not have any significant
solubility in phosphate buffer. Our finding that M2-10, M2-14, and
M2-18 all form mostly
-sheet structures in both the presence of
DMPC/DMPG lipid vesicles (CD studies) and in lipid multilayers (IR
studies) probably results from a hydrophobic mismatch that causes these
peptides first to aggregate into sheet structures followed by
interaction of the sheet structures with the lipids. We did not
ascertain whether the aggregates penetrate into the bilayers or
interact with the head groups. The low deuterium/proton exchange rates
observed for these peptides (Table II) is consistent both with membrane
penetration or extensive intermolecular hydrogen bonding.
The difference in the tilt angles of the four peptides that form
helical structures in the vesicles and multilayers (M2-22, M2-26,
M2-30B, and M2-35) may also be the result of hydrophobic mismatch. If
one assumes that the hydropathy predictions are correct (18, 56, 57),
then only about 17, 21, 25, and 25 residues, respectively, of these
peptides should be in the hydrocarbon domain of the membrane. The SNYSS
sequence should be outside the membrane core. If this is the case, then
it is likely that M2-22 forms a helix that does not completely span the
bilayer, that M2-26 just spans the bilayer, and that both M2-30B and
M2-35 would be too long for the bilayer. Thus, the orientation studies
that show almost no tilt for M2-22 and M2-26 and tilt angles of 36 and
34° for M2-30B and M2-35 suggest that the shorter helices integrate perpendicular to the bilayer, whereas the longer helix can only be
accommodated if they tilt to relieve the hydrophobic mismatch that
would result. This conclusion is consistent with the findings on the
WALP peptides that reported small tilt angles (~10-15°) for
peptides shorter than the bilayer and large tilt angles (~30°) for
peptides expected to be significantly longer than the bilayer (58). It
is also consistent with results on synthetic peptide segments of
bacteriorhodopsin that contained 35-45 residues and also exhibited
tilt angles between 30 and 40° (59) and with findings on an
18-residue peptide fragment of the sixth TMD of Ste2p that had a very
small tilt angle (22).
One can compare the results obtained herein with the M2 peptides with
those found from the crystal structure on rhodopsin (3, 4). Of the
seven transmembrane helices of this GPCR, four have tilt angles of
25-33°, and three have tilt angles of from 1 to 9°. It is
intriguing that with the exception of helix VI, the domains with the
largest number of residues (30-34 amino acids) have large tilt angles.
In contrast, the domain with the smallest tilt angle (domain IV) has
the fewest residues (19 amino acids) in the lipid environment. It is
difficult to analyze the rhodopsin transmembrane domains from the
perspective of hydrophobic mismatch, because the light reception
receptor was crystallized from mixed micelles. Furthermore, many of the
domains of this GPCR are highly kinked. Nevertheless, the fact that the
synthetic peptides corresponding to transmembrane domain 2 of Ste2p
exhibit tilt angles that are in the range of those found for the
transmembrane regions from the crystal structure of rhodopsin is very
interesting, leading to speculation that studies with single
transmembrane domains may indeed mirror tilt angles of transmembrane
domains in the native proteins.
The most significant anomaly in the present study was the observation
that M2-30 formed a
-sheet structure in TFE/H2O (50:50) in the presence of DMPC/DMPG vesicles and in DMPC/DMPG multilayers. The
finding again points to the relevance of results from studies in TFE
water mixtures to the lipid milieu. In the case of M2-30, the peptide
is predicted to have 4-7 residues that are in the extracellular loop
of Ste2p and 23-26 residues in the bilayer (18, 56, 57). It is likely
that this span is too long for the bilayer, thereby causing a
hydrophobic mismatch. Unlike M2-35, M2-30 does not contain the
hydrophilic sequence (RSRKT) at the amine (cytosolic) end. This
positively charged sequence is expected to interact favorably with the
negatively charged lipid head groups and to stabilize the tilted M2-35.
Lack of this end group in M2-30 leads to unfavorable interactions at
the N terminus of the peptide and exclusion from the membrane. This
exclusion results in an aggregated peptide that then somehow associates
with the DMPC/DMPG vesicles and multilayers. The fact that no CD or IR
spectra could be measured for M2-30 in phosphate buffer excludes the
possibility that free peptide is contributing to the spectra examined.
In the study of the WALP peptides cited above, it was found that replacement of the WW sequence at the termini of the peptides with KK
sequences resulted in a marked increase in the peptide insertion in the
bilayer (58). This supports the contention that the hydrophilic
residues at the peptide termini can provide thermodynamically favorable
interactions with the lipid head groups that can overcome hydrophobic mismatch.
The importance of the nature and placement of the residues at the
termini is illustrated by M2-30B. This 30-residue peptide contains the
same hydrophobic core residues as M2-30, but five cytoplasmic loop
residues (RSRKT) were included and five extracellular loop residues
(SNYSS) were omitted. As judged by both CD and IR analysis, M2-30B
forms a helical structure in bilayers (Figs. 2-4). This suggests that
loop residues on both termini of a transmembrane peptide are not
required for membrane insertion and helix formation. However, the fact
that M2-30B but not M2-30 was helical in lipid bilayers suggests that
residues at the N and C termini of a transmembrane domain influence its
biophysical properties, in particular, its interaction with lipid
membranes. In the case examined herein, the highly cationic RSRKT
sequence of the cytoplasmic loop appears to interact favorably with the
negatively charged phospholipid head groups stabilizing the insertion
of the tilted M2-30B core. In contrast, the polar SNYSS sequence in
M2-30 apparently does not interact strongly enough to compensate for
the hydrophobic mismatch of the same core residues. If this finding
proves to be general for other transmembrane domains, it may have
implications for the attachment of lysine residues at both termini of a
transmembrane core. Such lysine attachment is now commonly used to
increase membrane peptide solubility and thereby facilitate biophysical studies on these peptides (60, 61).
In conclusion, the results of this study show that the chain length
chosen for peptide surrogates used to examine regions of GPCRs is a
critical variable. In the case of the second transmembrane domain of
Ste2p, helices could not begin forming with peptides containing fewer
than 22 residues. This critical chain length was characteristic of the
lipid environment, because the same peptides formed helical structures
in TFE and in TFE containing up to 50% water. For longer peptides, the
residues at the termini played an important role in determining whether
helices could integrate into the membrane. Thus, the choice of the
termini of peptide fragments should be done judiciously and following
information learned using hydropathy analysis. Since both the overall
conformational tendency of the peptide and the tilt angle in the
membrane bilayer is influenced by length and termini, these factors
should be considered in applying results on model peptides to the
intact integral membrane protein.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants GM22086 and GM22087.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Dept. of Chemistry,
College of Staten Island, CUNY, Staten Island, NY 10301. Tel.: 718-982-3896; Fax: 718-982-3910; E-mail:
naider@postbox.csi.cuny.edu.
Published, JBC Papers in Press, February 19, 2002, DOI 10.1074/jbc.M111382200
2
B. Arshava and F. Naider, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
Fmoc, N-(9-fluorenyl)methoxycarbonyl;
FTIR, Fourier transform
infrared;
ATR-FTIR, attenuated total reflection Fourier transform
infrared;
DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine;
DMPG, 1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol))
sodium salt;
HPLC, high performance liquid chromatography;
GPCR, G
protein-coupled receptor;
Ste2p,
-factor receptor encoding
the STE2 gene from S. cerevisiae;
TFE, 2,2,2-trifluoroethanol;
tBu, tert-butyl;
TMD, transmembrane domain.
 |
REFERENCES |
| 1.
|
Engelman, D. M.,
Steitz, T. A.,
and Goldman, A.
(1986)
Annu. Rev. Biophys. Biophys. Chem.
15,
321-353[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Engelman, D. M.,
and Steitz, T. A.
(1981)
Cell
23,
411-422[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Palczewski, K.,
Kumasaka, T.,
Hori, T.,
Behnke, C.,
Motoshima, H.,
Fox, B. A.,
Trong, I. L.,
Teller, D. C.,
Okada, T.,
Stenkamp, R. E.,
Yamamota, M.,
and Miyano, M.
(2000)
Science
289,
739-745[Abstract/Free Full Text]
|
| 4.
|
Teller, D. C.,
Okada, T.,
Behnke, C. A.,
Palczewski, K.,
and Stenkamp, R. E.
(2001)
Biochemistry
40,
7761-7772[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Pebay-Peyroula, E.,
Rummel, G.,
Rosenbusch, J. P.,
and Landau, E. M.
(1997)
Science
277,
1676-1681[Abstract/Free Full Text]
|
| 6.
|
Kimura, Y.,
Vassylyev, D. G.,
Miyazawa, A.,
Kidera, A.,
Matsushima, M.,
Mitsuoka, K.,
Murata, K.,
Hirai, T.,
and Fujiyoshi, Y.
(1997)
Nature
389,
206-211[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Mitsuoka, K.,
Hirai, T.,
Murata, K.,
Miyazawa, A.,
Kidera, A.,
Kimura, Y.,
and Fujiyoshi, Y.
(1999)
J. Mol. Biol.
286,
861-882[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Garavito, R. M.
(1998)
Curr. Opin. Struct. Biotechnol.
9,
344-349[CrossRef]
|
| 9.
|
Tsukihara, T.,
and Lee, S. J.
(1999)
J. Synchrotron Radiat.
6,
918-927[CrossRef]
|
| 10.
|
Albert, A. D.,
and Yeagle, P. L.
(2000)
Methods Enzymol.
315,
107-115[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Deber, C. M.,
Liu, L. P.,
and Wang, C.
(1999)
J. Pept. Res.
54,
200-205[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Chou, P. Y.,
and Fasman, G. D.
(1974)
Biochemistry
13,
211-222[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Liu, L. P.,
and Deber, C. M.
(1998)
J. Biol. Chem.
273,
23645-23648[Abstract/Free Full Text]
|
| 14.
|
Liu, L. P.,
and Deber, C. M.
(1998)
Biopolymers
47,
41-62[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Pillai, V. N.,
Rajasekharan, V. N.,
and Mutter, M.
(1981)
Acc. Chem. Res.
14,
122-130
|
| 16.
|
Dohlman, H. G.,
Thorner, J.,
Caron, M. G.,
and Lefkowitz, R. J.
(1991)
Annu. Rev. Biochem.
60,
653-688[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Dohlman, H. G.,
and Thorner, J. W.
(2001)
Annu. Rev. Biochem.
70,
703-754[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Reddy, A. P.,
Tallon, M. A.,
Becker, J. M.,
and Naider, F.
(1994)
Biopolymer
34,
679-689[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Xie, H.,
Ding, F. -X.,
Schreiber, D.,
Eng, G.,
Liu, S.-F.,
Arshava, B.,
Arevalo, E.,
Becker, J. M.,
and Naider, F.
(2000)
Biochemistry
39,
15462-15474[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Ding, F.-X.,
Xie, H.,
Arshava, B.,
Becker, J. M.,
and Naider, F.
(2001)
Biochemistry
40,
8945-8954[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Arshava, B.,
Liu, S. F.,
Jiang, H.,
Breslav, M.,
Becker, J. F.,
and Naider, F.
(1998)
Biopolymers
46,
343-357[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Valentine, K. G.,
Liu, S. -F.,
Marassi, F. M.,
Veglia, G.,
Opella, S. J.,
Ding, F.-X.,
Wang, S.-H.,
Arshava, B.,
Becker, J. M.,
and Naider, F.
(2001)
Biopolymers
59,
243-256[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Carpenter, K. A.,
Schmidt, R.,
Yue, S. Y.,
Hodzic, L.,
Pou, C.,
Payza, K.,
Godbout, C.,
Brown, W.,
and Roberts, E.
(1999)
Biochemistry
38,
15295-15304[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Greenfield, N.,
and Fasman, G. D.
(1969)
Biochemistry
8,
4108-4116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Wu, C. S. C.,
Ikeda, K.,
and Yang, J. T.
(1981)
Biochemistry
20,
566-570[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Chen, Y. H.,
Yang, J. T.,
and Chau, K. H.
(1974)
Biochemistry
13,
3350-3359[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Hunt, J. F.,
Rath, P.,
Rothschild, K. J.,
and Engelman, D. M.
(1997)
Biochemistry
36,
15177-15192[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Arkin, I. T.,
Russ, W. P.,
Lebendiker, M.,
and Schuldiner, S.
(1996)
Biochemistry
35,
7233-7238[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Smith, S. O.,
Jonas, R.,
Braiman, M.,
and Bormann, B. J.
(1994)
Biochemistry
33,
6334-6341[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Tamm, L. K.,
and Talulian, S. A.
(1993)
Biochemistry
32,
7720-7726[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Harrick, N. J.
(1967)
Internal Reflection Spectroscopy
, Interscience Publisher, New York
|
| 32.
|
Menikh, A.,
Saleh, M. T.,
Gariepy, J.,
and Boggs, J. M.
(1997)
Biochemistry
36,
15865-15872[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Johnson, W. C., Jr.
(1988)
Annu. Rev. Biophys. Biophys. Chem.
17,
145-166[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Pysh, E. S.
(1966)
Proc. Natl. Acad. Sci. U. S. A.
56,
825-832[Free Full Text]
|
| 35.
|
Woody, R. W.
(1969)
Biopolymers
8,
669-683[CrossRef]
|
| 36.
|
Madison, V.,
and Schellman, J.
(1972)
Biopolymers
11,
1041-1076[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Grebow, P. E.,
and Hooker, T. M., Jr.
(1975)
Biopolymers
14,
871-881[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Ziegler, S. M.,
and Bush, C. A.
(1971)
Biochemistry
10,
1330-1335[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Braiman, M. S.,
and Rothschild, K. J.
(1988)
Annu. Rev. Biophys. Biophys. Chem.
17,
541-570[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Zhang, Y. P.,
Lewis, R. N.,
Hodges, R. S.,
and McElhaney, R. N.
(1992)
Biochemistry
31,
11572-11578[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Earnest, T. N.,
Herzfeld, J.,
and Rothschild, K. J.
(1990)
Biophys. J.
58,
1539-1546[Abstract/Free Full Text]
|
| 42.
|
Holloway, P. W.,
and Buchheit, C.
(1990)
Biochemistry
29,
9631-9637[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Brenziger, J. E.,
and Methot, N.
(1995)
J. Biol. Chem.
270,
29129-29137[Abstract/Free Full Text]
|
| 44.
|
Arkin, I. T.,
Rothman, M.,
Ludlam, C. F. C.,
Aimoto, S.,
Engelman, D. M.,
Rothschild, K. J.,
and Smith, S. O.
(1995)
J. Mol. Biol.
248,
824-834[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Sharon, M.,
Oren, Z.,
Shai, Y.,
and Anglister, J.
(1999)
Biochemistry
38,
15305-15316 |